Lancashire (LRE) Competitors

Mediclinic International (LON:MDC) and Lancashire (LON:LRE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Do insiders and institutionals hold more shares of MDC or LRE?

39.2% of Mediclinic International shares are owned by institutional investors. Comparatively, 60.5% of Lancashire shares are owned by institutional investors. 48.9% of Mediclinic International shares are owned by company insiders. Comparatively, 0.6% of Lancashire shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Is MDC or LRE more profitable?

Lancashire has a net margin of 37.12% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 10.76% beat Mediclinic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mediclinic International	4.99%	5.50%	2.30%
Lancashire	37.12%	10.76%	6.75%

Is MDC or LRE a better dividend stock?

Mediclinic International pays an annual dividend of GBX 3 per share. Lancashire pays an annual dividend of GBX 18 per share and has a dividend yield of 3.0%. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Lancashire pays out 34.3% of its earnings in the form of a dividend. Lancashire is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has higher earnings & valuation, MDC or LRE?

Lancashire has lower revenue, but higher earnings than Mediclinic International. Mediclinic International is trading at a lower price-to-earnings ratio than Lancashire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mediclinic International	£3.38B	0.00	£169M	£0.23	N/A
Lancashire	£536.12M	3.43	£199.02M	£52.49	11.60

Does the media refer more to MDC or LRE?

In the previous week, Mediclinic International's average media sentiment score of 0.00 beat Lancashire's score of -0.15 indicating that Mediclinic International is being referred to more favorably in the media.

Company	Overall Sentiment
Mediclinic International	Neutral
Lancashire	Neutral

Do analysts prefer MDC or LRE?

Lancashire has a consensus price target of GBX 770, suggesting a potential upside of 26.44%. Given Lancashire's stronger consensus rating and higher probable upside, analysts plainly believe Lancashire is more favorable than Mediclinic International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mediclinic International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lancashire	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in MDC or LRE?

Lancashire received 115 more outperform votes than Mediclinic International when rated by MarketBeat users. However, 57.33% of users gave Mediclinic International an outperform vote while only 44.53% of users gave Lancashire an outperform vote.

Company	Underperform	Outperform
Mediclinic International	Outperform Votes 219 57.33%	Underperform Votes 163 42.67%
Lancashire	Outperform Votes 334 44.53%	Underperform Votes 416 55.47%

Which has more risk & volatility, MDC or LRE?

Mediclinic International has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Lancashire has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500.

Summary

Lancashire beats Mediclinic International on 13 of the 18 factors compared between the two stocks.